Legal Representation
Attorney
Deborah J. Peckham
USPTO Deadlines
Next Deadline
239 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-03-10)
Due Date
March 10, 2026
Grace Period Ends
September 10, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 11, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Mar 11, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Mar 11, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Mar 11, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Mar 11, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Mar 10, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Mar 10, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Feb 7, 2020 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Feb 6, 2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Jan 9, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jan 9, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jan 6, 2020 | ALIE | A | ASSIGNED TO LIE |
| Dec 16, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jul 11, 2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jun 25, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jun 25, 2019 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Jun 25, 2019 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
| Jun 22, 2019 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Jun 22, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jun 12, 2019 | IUAF | S | USE AMENDMENT FILED |
| Jun 12, 2019 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Dec 15, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Dec 13, 2018 | EXT4 | S | SOU EXTENSION 4 FILED |
| Dec 13, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Dec 13, 2018 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Jun 1, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 30, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED |
| May 30, 2018 | EXT3 | S | SOU EXTENSION 3 FILED |
| May 30, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Dec 14, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Dec 12, 2017 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Dec 12, 2017 | EXT2 | S | SOU EXTENSION 2 FILED |
| Dec 12, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 14, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jun 12, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jun 12, 2017 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jun 12, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Dec 13, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Oct 18, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Oct 18, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Sep 28, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sep 10, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 9, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 8, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 8, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Mar 9, 2016 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Mar 9, 2016 | GPRA | F | PRIORITY ACTION E-MAILED |
| Mar 9, 2016 | CPRA | R | PRIORITY ACTION WRITTEN |
| Feb 29, 2016 | DOCK | D | ASSIGNED TO EXAMINER |
| Nov 14, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Detailed Classifications
Class 009
Clinical research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; clinical research laboratory analyzers for measuring, testing and analyzing basic metabolic indicators, namely, glucose, electrolyte, fluid balance, kidney function
First Use Anywhere:
20171000
First Use in Commerce:
20171000
Class 010
Blood analyzers for medical diagnostic and critical care diagnostic use; medical apparatus, namely, medical instruments for testing, analysis and reporting on basic metabolic indicators, namely, glucose, electrolyte, fluid balance, kidney function; apparatus for blood analysis for use by physicians for diagnostic and critical care diagnostic purposes
First Use Anywhere:
20171000
First Use in Commerce:
20171000
Classification
International Classes
009
010
USPTO Documents
Loading USPTO documents...